is semaglutide on shortage Explainer: What's behind the scramble for semaglutide? Makers of compounded Wegovy, Ozempic

A separate study published in August 2025 found patients prescribed semaglutide or tirzepatide for Type 2 diabetes had an increased risk of NAION and other optic nerve disorders, but the overall risk was very low

enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC) nave to second-generation antiandrogens

FDA-Approved Medications Wegovy, Zepbound, Ozempic, and Mounjaro are specific finished products that have undergone extensive FDA review

SERAT3;1 and -3;2 are unable to bind OAS-TL (Mller et al., 2017)

What clinics are seeing: Peptide-forward clinics report that NAD+ supplementation (oral NMN or subcutaneous NAD+ injections) alongside GLP-1 reduces patient-reported fatigue and brain fog in the 6080% range within 24 weeks